Objective: To compare the dose effectiveness of low to moderate doses
of methadone in a sample of a contemporary population of opioid abuser
s, because the optimal dosing of methadone in the treatment of opioid
dependence remains an issue. Design: A randomized, double-blind, place
bo-controlled study. Setting: A methadone treatment research clinic. P
atients: Participants (n = 247) were opioid-dependent patients with a
high rate of cocaine use. Intervention: All participants were initiall
y treated with active methadone for a minimum of 5 weeks and then rece
ived 15 weeks of stable dosing at 50, 20, or 0 mg per day. Individual
counseling and group therapy were included. Measurements: Treatment re
tention and illicit drug use as determined by intensive urine monitori
ng. Results: Retention was better for patients who remained on active
medication. By treatment week 20, retention was 52.4% for the 50-mg, 4
1.5% for the 20-mg, and 21.0% for the 0-mg group (50 versus 0 and 20 v
ersus 0, P < 0.05; 50 versus 20, P > 0.05). Only the 50-mg treatment g
roup had a reduced rate of opioid-positive urine samples (56.4% versus
67.6% and 73.6% for the 20-mg and 0-mg groups, respectively; P < 0.05
) and cocaine-positive urine samples (52.6% versus 62.4% and 67.1% for
the 20- and 0-mg groups, respectively; P < 0.05). Conclusions: There
is a dose-response effect for methadone treatment. Doses as low as 20
mg may improve retention but are inadequate for suppressing illicit dr
ug use.